Targeted therapy of multiple myeloma
Nathan G Dolloff1, Giampaolo Talamo
1Penn State Hershey Cancer Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA. dolloffn@gmail.com
Advances in Experimental Medicine and Biology
|January 5, 2013
Summary
Multiple myeloma (MM) is a complex blood cancer. Research explores its genetic basis and targeted therapies to improve patient outcomes, as MM remains largely incurable.
Area of Science:
- Hematologic oncology
- Cancer genomics
Background:
- Multiple myeloma (MM) is the second most common blood cancer, characterized by malignant plasma cell accumulation in bone marrow.
- MM presents with diverse symptoms like hypercalcemia, renal issues, anemia, and bone lesions.
- The disease is genetically heterogeneous, featuring genomic instability and various oncogenic pathway aberrations.
Purpose of the Study:
- To review the genetic underpinnings of multiple myeloma.
- To discuss recent clinical trial results for targeted MM therapies.
- To explore emerging experimental treatments and their molecular basis.
Main Methods:
- Review of genetic abnormalities in MM, including common translocations.
- Analysis of clinical trial data for targeted agents (IMiDs, proteasome inhibitors).
- Discussion of ongoing experimental therapies and their rationale.
Main Results:
- Novel agents like IMiDs and bortezomib have improved MM response rates and survival.
- Targeted therapies show effectiveness in managing MM.
- Ongoing research is identifying new therapeutic strategies and targets.
Conclusions:
- Despite advances, multiple myeloma remains incurable for most patients.
- Understanding MM's genetic landscape is crucial for developing new treatments.
- Targeted and experimental therapies offer promise for future MM management.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
25
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
25
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
01:15Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K